FLT1 and neoplasm: The VEGFR1, c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK) signaling pathways were involved in actein’s anti-angiogenic activities, which might subsequently inhibit the orthotopic tumor growth and metastasis of tumor cells in mice.